Brainsway Completes Patient Recruitment in Multicenter Major Depression Trial JERUSALEM, Israel, Dec. 9, 2011 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that patient recruitment in its multicenter clinical trial for major depression was completed in...

Brainsway Announces Interim Results of an Animal Study of the Effects of Deep TMS on Macular Degeneration JERUSALEM, Dec. 9, 2011 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received interim results from an animal study being conducted at the Sheba Medical Center to...

Brainsway Receives IDE Approval to Begin Multicenter Clinical Trial for Bipolar Disorder JERUSALEM, Nov. 1, 2011 (GLOBE NEWSWIRE) -- Further to that stated in Brainsway's (TASE:BRIN) periodic report for 2010, the Company is pleased to announce that it has received an Investigational...

Brainsway Reports Positive Interim Results in Alzheimer's Trial JERUSALEM, Oct. 4, 2011 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received additional interim results of a clinical trial being conducted at the Ichilov Medical...

Brainsway Wins Israeli Ministry of Health Approval for Deep TMS Device to Treat Major Depression, Bipolar Disorder and Schizophrenia JERUSALEM, Oct. 3, 2011 (GLOBE NEWSWIRE) -- Brainsway Ltd. (TASE:BRIN) is pleased to announce that it has received approval from Israel's Ministry of Health to market and sell the Company's Deep TMS...